Cold & Cough Remedies - Kazakhstan

  • Kazakhstan
  • In Kazakhstan, the revenue in the Cold & Cough Remedies market market reaches US$110.70m in 2024.
  • It is estimated that the market will experience an annual growth rate of 6.45% from 2024 to 2029 (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States generates the highest revenue in this market, amounting to US$11,190.00m in 2024.
  • Taking into account the total population figures, each person in Kazakhstan contributes to a revenue of US$5.58 in 2024.
  • Despite the harsh climate in Kazakhstan, the demand for cold & cough remedies in the OTC Pharmaceuticals market is steadily increasing.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Kazakhstan is experiencing steady growth due to increasing customer preferences for over-the-counter medications, as well as local special circumstances and underlying macroeconomic factors.

Customer preferences:
In Kazakhstan, customers have shown a growing preference for over-the-counter medications to treat cold and cough symptoms. This can be attributed to several factors, including the convenience of purchasing these remedies without a prescription and the increasing awareness of self-care and prevention. Customers are also seeking products that provide quick relief and are effective in alleviating symptoms such as congestion, coughing, and sore throat.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Kazakhstan is the rising demand for natural and herbal remedies. Customers are becoming more health-conscious and are seeking products that are perceived as safer and have fewer side effects. As a result, there is a growing market for herbal cough syrups, lozenges, and teas that are made from natural ingredients such as honey, ginger, and eucalyptus.Another trend in the market is the increasing availability and popularity of combination products. These products offer a combination of ingredients that target multiple symptoms, such as congestion, coughing, and fever. Customers are drawn to these products as they provide a convenient solution for managing multiple symptoms with a single medication.

Local special circumstances:
Kazakhstan has a cold climate, with long winters and low temperatures. This creates a conducive environment for the spread of cold and cough viruses, leading to a higher incidence of these respiratory illnesses. As a result, there is a constant demand for cold and cough remedies throughout the year.Additionally, the healthcare infrastructure in Kazakhstan is still developing, and access to healthcare services may be limited in remote areas. This further drives the demand for over-the-counter remedies, as customers rely on self-medication to manage their cold and cough symptoms.

Underlying macroeconomic factors:
The growing middle class in Kazakhstan has contributed to the increasing demand for cold and cough remedies. As disposable incomes rise, customers have more purchasing power and are willing to spend on healthcare products. This has led to an expansion of the consumer market for over-the-counter medications, including cold and cough remedies.Furthermore, the government of Kazakhstan has been actively promoting the development of the pharmaceutical industry. This includes initiatives to attract foreign investment, improve healthcare infrastructure, and enhance the regulatory framework. These efforts have created a favorable business environment for pharmaceutical companies, leading to increased availability and accessibility of cold and cough remedies in the market.In conclusion, the Cold & Cough Remedies market in Kazakhstan is growing due to customer preferences for over-the-counter medications, the demand for natural and herbal remedies, local special circumstances such as the cold climate and limited healthcare access, and underlying macroeconomic factors such as the growing middle class and government support for the pharmaceutical industry.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)